Market›Health Care›Pharmaceuticals›Pharmaceuticals
GSK PLC ADR ADR

GSK

$54.44Apr 26, 2021 – Apr 24, 2026
Health CarePharmaceuticals$115.45B
MVM
+$1.26B
TD Variance
0.032

Every news event mapped to its market reaction — 69 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-10-28+4.5%newsYahoo FinanceHere's Why GSK (GSK) is a Strong Growth Stock - Yahoo Finance
2026-04-15-4.5%newsSeeking AlphaWhite House reportedly eyeing former deputy surgeon general to lead CDC
2026-02-02+3.7%newsMorningstar Australia10 best global blue-chip stocks to buy for the long term - Morningstar Australia
2026-02-19-3.2%legalSeeking AlphaCDC said to delay vaccine panel meeting after lawsuit challenging its composition
2026-03-25+3.1%earningsSeeking AlphaWhite House misses deadline for CDC director nominee
2026-04-20-3.0%M&AMT NewswiresAnaptysBio Completes Spinoff of First Tracks Biotherapeutics; Shares Surge
2026-04-20-3.0%newsSimply Wall St.GSK Respiratory Breakthrough And Pipeline Advances Reshape Long Term Outlook
2026-04-20-3.0%earningsMarketBeatGSK PLC Sponsored ADR $GSK Shares Sold by Miller Howard Investments Inc. NY - MarketBeat
2026-04-23-2.6%legalPR NewswireCipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA
2026-04-23-2.6%analystChartMillGSK Forecast, Price Target & Analyst Ratings | GSK PLC-SPON ADR (NYSE:GSK) - ChartMill
2026-03-27+2.6%newsSeeking AlphaFormer CDC advisor says White House pulling back on vaccine policy
2021-11-18-2.4%analysteToroGSK Stock Price | Analyst Target 70.00 & Hold Consensus - eToro
2026-03-03-2.3%newsSeeking AlphaCDC acting director calls for measles vaccination
2025-03-10+2.1%newsMorningstarThe Best Defensive Stocks to Buy Now - Morningstar
2026-02-25-2.1%newsSeeking AlphaViiV says early-stage data on VH184 for HIV could support twice-yearly dosing
2026-02-25-2.1%newsSeeking Alpha15 states sue Trump administration over changes to U.S. vaccine schedule
2026-02-25-2.1%M&ASeeking AlphaGSK to acquire Canada's 35Pharma for $950M in cash
2025-03-28+1.9%newsYahoo FinanceIs GSK plc (GSK) the Best ADR Stock to Buy According to Hedge Funds? - Yahoo Finance
2026-03-26+1.9%newsSeeking AlphaAnti-vaccine group asks RFK Jr. to add more vaccine injuries to compensation program
2026-03-26+1.9%newsSeeking AlphaGSK plc (GSK) Presents at Goldman Sachs 9th Annual Biopharma Innovation Summit Transcript
2022-03-11+1.8%newsZacks Investment ResearchDividend History - GSK PLC Sponsored ADR (GSK) - Zacks Investment Research
2025-11-04+1.6%newsMorningstar3 Dividend Stocks for November 2025 - Morningstar
2026-03-19+1.5%legalSeeking AlphaGSK granted FDA nod for Lynavoy for itch associated with rare liver disorder
2026-04-19-1.5%newsSeeking AlphaGSK: 'Strong Buy' On Mo-Rez Oncology Expansion Potential
2026-04-22-1.5%earningsZacksEuropean Commission Approves MRNA's COVID-19-Influenza Combo Shot
2026-04-22-1.5%earningsZacksGSK (GSK) Earnings Expected to Grow: Should You Buy?
2026-03-13-1.4%legalSeeking AlphaGSK wins FDA label expansion for RSV vaccine, Arexvy
2026-04-08+1.4%executiveSeeking AlphaCEO of top pharma lobby PhRMA to resign: Endpoints News
2026-04-08+1.4%newsSeeking AlphaRFK Jr. changes rules to select CDC vaccine advisors after legal setback
2026-04-08+1.4%newsSeeking AlphaGSK gets China approval for Exdensur in nasal polyps, expanding respiratory portfolio
2025-04-23-1.3%newsTradingViewGSKH Stock Fund Price and Chart — AMEX:GSKH - TradingView
2023-12-20+1.3%newsMorningstarBest International Companies to Own: 2026 Edition - Morningstar
2026-03-16-1.2%M&ASeeking AlphaRFK Jr. dealt blow as judge blocks changes to childhood immunization schedule
2025-12-31+1.2%newsAD HOC NEWSThe Truth About GSK plc (ADR): Is Wall Street Sleeping On This Pharma Beast? - AD HOC NEWS
2024-10-21-1.2%newsMorningstarThis Dividend Stock With a 4% Yield Is a Buy After Some Positive News - Morningstar
2026-02-01+1.2%newsAD HOC NEWSGSK plc (ADR): Quiet Rally, Loud Expectations – Is the Stock Finally Escaping Its Legal Overhang? - AD HOC NEWS
2026-02-24-1.1%newsSeeking AlphaCDC vaccine panel to meet in March after delay
2026-02-24-1.1%M&ASeeking AlphaGSK inks licensing deal worth up to $1B with Chinas Frontier Bio
2026-01-01+1.0%newsAD HOC NEWSThe Truth About GSK plc (ADR): Is This ‘Boring’ Stock Quietly Becoming a Power Play? - AD HOC NEWS
2026-03-06+0.9%newsSeeking AlphaTylenol use in pregnancy fell after Trumps autism warning: study
2026-01-16-0.9%newsAD HOC NEWSGSK plc (ADR): Defensive Pharma Giant Tests Investors’ Patience As Shares Slip Despite Solid Pipel - AD HOC NEWS
2025-07-03-0.9%newsMorningstar AustraliaThe 10 best US companies to invest in now - Morningstar Australia
2026-03-21-0.8%legalAD HOC NEWSGSK plc (ADR) stock surges on FDA approval for Lynavoy as pipeline momentum builds for 2026 - AD HOC NEWS
2024-02-19+0.7%newsCNNGSK Stock Quote Price and Forecast - CNN
2026-04-17-0.6%earningsZacksWill Livmarli Continue to Aid Mirum's Top Line in Q1 Earnings?
2026-04-17-0.6%newsSeeking AlphaTrump nominates Erica Schwartz to lead CDC, ending months-long search
2026-01-05+0.6%newsAD HOC NEWSThe Truth About GSK plc (ADR): Viral Hype Or Sneaky Safe Bet For Your Portfolio? - AD HOC NEWS
2026-04-16-0.5%newsZacksSMMT Stock Up 24% in Three Months: Here's What You Need to Know
2026-04-16-0.5%newsMT NewswiresEuropean Equities Traded in the US as American Depositary Receipts Declining in Thursday Trading
2026-04-16-0.5%earningsMarketBeatGSK PLC Sponsored ADR (NYSE:GSK) Sees Significant Growth in Short Interest - MarketBeat
2026-03-31-0.4%newsSeeking AlphaGSK: Chinese Expansion And Fine Financials
2022-07-23-0.4%analystZacks Investment ResearchWhat is the current Price Target and Forecast for GSK PLC Sponsored ADR (GSK) - Zacks Investment Research
2026-01-21+0.4%newsAD HOC NEWSGSK plc (ADR): Defensive pharma heavyweight tests investors’ patience as Wall Street edges cautiou - AD HOC NEWS
2026-03-10-0.4%newsSeeking AlphaGSK gains approval of leucovorin for rare genetic disorder
2025-12-15+0.4%analystTechStock²GSK plc Stock News & Forecasts (Dec. 15, 2025): FDA Catalyst for Depemokimab, EU Backs Nucala and Arexvy, Analysts Map the Path Ahead - TechStock²
2026-03-18-0.3%M&ASeeking AlphaGSK Expanding Fast - Oncology, HIV, And Smart Acquisitions
2026-03-14-0.3%newsSeeking AlphaAmgen and GSK said to be adding products on TrumpRx
2026-04-12+0.3%newsSeeking AlphaGSK bets big on cancer comeback with aggressive trial push
2026-04-12+0.3%earningsMarketBeatGSK PLC Sponsored ADR $GSK Shares Acquired by Prime Capital Investment Advisors LLC - MarketBeat
2026-03-11-0.2%newsSeeking AlphaGSK plc (GSK) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
2025-03-20-0.2%newsMorningstar AustraliaMagnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up? - Morningstar Australia
2026-04-02+0.1%expansionSeeking AlphaUK reaches agreement with US for British drugs to be tariff free
2026-04-02+0.1%newsAD HOC NEWSGSK plc (ADR) Stock: ViiV Healthcare Ownership Restructured as Pfizer Exits, Strengthening GSK's HIV - AD HOC NEWS
2021-07-18+0.1%earningsZacks Investment ResearchWhat date does GSK PLC Sponsored ADR's (GSK) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research
2026-04-10+0.1%legalSeeking AlphaHHS Secretary RFK Jr. overhauls CDC vaccine advisory committee rules
2026-04-10+0.1%earningsSeeking AlphaGSK withdraws autism drug application backed by Trump after recent submission
2026-01-28-0.1%earningsFinvizGSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth - Finviz
2026-04-25—M&ASimply Wall St.4DMedical GSK Lung Imaging Deal And What It May Mean For Investors
2026-04-24—newsMT NewswiresAnaptysBio Gets Favorable Ruling by Delaware Chancery Court in Tesaro's Anticipatory Breach Claim
tickerdossier.comtickerdossier.substack.com